Cyclica Inc.
Cyclica is commercializing Ligand Explorer, a pre-computed data integration platform that brings together the growing deluge of biological and chemical data being deposited in academic data commons and indexes it for rapid search and the identification of protein-drug interactions. The goal is to change the way drug discovery is done by leveraging Big Data to streamline the drug design process and predict clinical outcomes of drug candidates prior to prohibitively expensive clinical trials. By utilizing these integrated databases, Ligand Explorer identifies problematic side effects, which are a major cause of attrition in drug discovery pipelines. The technology and approach enables the company’s clients, which includes pharma, biotech, and research institutes and hospitals, to better focus R&D efforts and resources on the most promising programs while also providing them with a wealth of data for more informed drug optimization strategies to overcome discovery and development hurdles.
National Ranking
2356th
in CanadaRegional Ranking
26098th
in North AmericaGlobal Ranking
60993rd
worldwideRankings by 